Atlas Trials

Tetraspan 6 Percent (%) Combined With Sterofundin ISO Versus Albumin 5 Percent (%) Combined With Sodium Chloride (NaCL)

Clinical trial NCT00936247 · TERMINATED

Trial details

NCT number
NCT00936247
Sponsor
B. Braun Melsungen AG
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Renal Insufficiency
Start date
2009-11-01
Primary completion
2010-09-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.